Cassava Sciences Stock Performance
| SAVA Stock | USD 3.25 0.14 4.13% |
On a scale of 0 to 100, Cassava Sciences holds a performance score of 8. The firm shows a Beta (market volatility) of 0.5, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cassava Sciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cassava Sciences is expected to be smaller as well. Please check Cassava Sciences' skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether Cassava Sciences' price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Cassava Sciences are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile basic indicators, Cassava Sciences sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 121.1 M | |
| Total Cashflows From Investing Activities | -103 K |
Cassava Sciences Relative Risk vs. Return Landscape
If you would invest 227.00 in Cassava Sciences on September 1, 2025 and sell it today you would earn a total of 98.00 from holding Cassava Sciences or generate 43.17% return on investment over 90 days. Cassava Sciences is currently generating 0.8394% in daily expected returns and assumes 8.0339% risk (volatility on return distribution) over the 90 days horizon. In different words, 72% of stocks are less volatile than Cassava, and 84% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cassava Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cassava Sciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cassava Sciences, and traders can use it to determine the average amount a Cassava Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1045
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SAVA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.03 actual daily | 72 72% of assets are less volatile |
Expected Return
| 0.84 actual daily | 16 84% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average Cassava Sciences is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cassava Sciences by adding it to a well-diversified portfolio.
Cassava Sciences Fundamentals Growth
Cassava Stock prices reflect investors' perceptions of the future prospects and financial health of Cassava Sciences, and Cassava Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cassava Stock performance.
| Return On Equity | -0.89 | ||||
| Return On Asset | -0.3 | ||||
| Current Valuation | 35.86 M | ||||
| Shares Outstanding | 48.31 M | ||||
| Price To Book | 1.92 X | ||||
| EBITDA | (141.15 M) | ||||
| Cash And Equivalents | 197.23 M | ||||
| Cash Per Share | 4.92 X | ||||
| Total Debt | 11.83 M | ||||
| Book Value Per Share | 3.02 X | ||||
| Cash Flow From Operations | (116.93 M) | ||||
| Earnings Per Share | (2.22) X | ||||
| Total Asset | 157.53 M | ||||
| Retained Earnings | (405.11 M) | ||||
About Cassava Sciences Performance
By analyzing Cassava Sciences' fundamental ratios, stakeholders can gain valuable insights into Cassava Sciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cassava Sciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cassava Sciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas. Cassava Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 24 people.Things to note about Cassava Sciences performance evaluation
Checking the ongoing alerts about Cassava Sciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cassava Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cassava Sciences is way too risky over 90 days horizon | |
| Cassava Sciences appears to be risky and price may revert if volatility continues | |
| Cassava Sciences has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (24.34 M) with loss before overhead, payroll, taxes, and interest of (56.99 M). | |
| Cassava Sciences currently holds about 197.23 M in cash with (116.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.92, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cassava Sciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 13.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Cassava Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cassava Sciences' stock is overvalued or undervalued compared to its peers.
- Examining Cassava Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cassava Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cassava Sciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cassava Sciences' stock. These opinions can provide insight into Cassava Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cassava Stock analysis
When running Cassava Sciences' price analysis, check to measure Cassava Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cassava Sciences is operating at the current time. Most of Cassava Sciences' value examination focuses on studying past and present price action to predict the probability of Cassava Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cassava Sciences' price. Additionally, you may evaluate how the addition of Cassava Sciences to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |